Discovery of New Plasma Protein Biomarkers Linked to Knee Osteoarthritis Through Human Proteome Integration: Insights from Mendelian Randomization and Initial In Vitro Studies - Summary - MDSpire
Advertisement
Discovery of New Plasma Protein Biomarkers Linked to Knee Osteoarthritis Through Human Proteome Integration: Insights from Mendelian Randomization and Initial In Vitro Studies
To identify candidate plasma proteins with potential causal associations with knee osteoarthritis (KOA) using Mendelian randomization, emphasizing the significance of these associations for future research and treatment.
Key Findings:
Galectin-3 was identified as a biomarker of KOA (OR = 1.07, 95% CI: 1.03–1.11, p = 0.00048), highlighting its potential role in KOA pathology.
Moderate-to-strong co-localization support for a shared causal variant was found (PPH4 = 77.3%, lead SNP: rs9323280).
In vitro experiments showed galectin-3 stimulation upregulated inflammatory cytokines and mediators in macrophages, suggesting a pro-inflammatory role.
Interpretation:
Galectin-3 may play a role in the inflammatory processes associated with KOA, suggesting its potential as a therapeutic target in clinical settings.
Limitations:
The study relies on observational data and may be affected by residual confounding.
In vitro findings require further validation in vivo.
The generalizability of findings may be limited to the studied populations.
Conclusion:
Galectin-3 is a promising plasma protein biomarker for KOA, with preliminary evidence supporting its involvement in inflammatory responses, warranting further investigation to validate these findings.
